• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Hygienic Packaging Technology

    Trends in Solid Oral Dosage Delivery

    5 Reasons Paper Has No Place in Contract Manufacturing

    Injectable Drug Delivery Trends

    Pharmaceutical Manufacturing Equipment Trends
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Amgen to Acquire Five Prime Therapeutics for $1.9B

    Genesis Drug Discovery & Development Acquires Integrated Analytical Solutions

    CureVac, Novartis Ink COVID Vax Mfg. Pact

    Innoforce and dMed Enter Development Collaboration

    Matica Biotechnology Breaks Ground on Cell and Gene Therapy Site
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Reed-Lane Facility Virtual Tour

    CureVac, Novartis Ink COVID Vax Mfg. Pact

    Matica Biotechnology Breaks Ground on Cell and Gene Therapy Site

    WuXi AppTec Completes OXGENE Acquisition

    Trends in Solid Oral Dosage Delivery
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Reed-Lane Facility Virtual Tour

    Hygienic Packaging Technology

    Reshaping the Pharmaceutical Supply Chain

    Serialization: Level 5 Solution

    Covectra Introduces Next-Gen Serialization Solution
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Genesis Drug Discovery & Development Acquires Integrated Analytical Solutions

    Innoforce and dMed Enter Development Collaboration

    Matica Biotechnology Breaks Ground on Cell and Gene Therapy Site

    Four Female Leaders Appointed to Cell & Gene CDMO

    Strata Oncology Unveils Strata PATH Trial
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Guide to Maintaining Validation of Older Facilities: Why, When and How

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Reed-Lane

    Emergent BioSolutions

    Adare Pharma Solutions

    Almac Group

    Aphena Pharma Solutions
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    PCI Pharma Services

    Emergent BioSolutions

    Adare Pharma Solutions

    Almac Group

    Cytovance Biologics
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Back Page

    India Eases Price Control On Novel Drugs

    No price cap for innovator products for 5 years

    India Eases Price Control  On Novel Drugs
    Related CONTENT
    • Softweb Solutions
    • A Different Kind of CRO
    • ANI Pharmaceuticals
    • Evotec AG, Immuneering in Discovery Alliance
    • Advanced Treatments in Rare Diseases
    S. Harachand, Contributing Editor03.06.19
    Drug makers can now launch their innovative products in the Indian market without fearing the possibility of price caps. India’s drug price regulator is not going to slap any restraint on the pricing of the drug for a period of five years starting from the day of commercializing the product in the country. But the firms are supposed to fulfill one criterion: The drug product should be patented in India.

    This is due to the new Drug Price (Control) Amendment Order (DPCO) 2019, the government announced through a notification, released at the beginning of January this year. The order, which has been brought about through amending the provisions in the existing DPCO 2013, now reads: “a manufacturer producing a new drug patented under the Indian Patent Act, 1970 (39 of 1970), [will be exempt from price control] for a period of five years from the date of commencement of its commercial marketing by the manufacturer in the country.” Earlier, such exemption was provided exclusively for the drugs developed indigenously.

    Many see the DPCO 2019 as a clear departure from the country’s stated policy of ensuring availability of good quality medicines at reasonable prices to all. Historically, a market highly-sensitive for pricing, India keeps a basket of medicines under a National List of Essential Medicines, known as Schedule-I of DPCO. The medicines that are included in the Schedule-I list automatically qualify for price control.

    DPCO, which lays down the procedures for regulating the prices of drugs, achieves the objective through the National Pharmaceutical Pricing Authority (NPPA), under the Ministry of Chemicals and Fertilizers. The drug-price watchdog fixes and revises the prices of pharmaceutical products through rigorous monitoring of their price points. Apart from the formulations of the drugs listed under statutory price control, NPPA can regulate the prices of other ‘de-controlled’ drugs as well, “if warranted in public interest.”

    An increasing number of ‘life-saving’ medicines like the ones meant for treating cancer as well as medical devices are being brought under the ambit of price control. Presently, the government has capped the prices of 855 medicines, according to reports quoting chemicals ministry officials. Drug makers often describe the ever-widening jaws of the price-control regime as “draconian.” Many of the firms either withdrew their innovator products or exited the market altogether on previous occasions blaming the unsustainable prices.

    The new exemptions for the drugs that allow them to be produced, developed and manufactured anywhere across the world by the patentee is expected to encourage new drug manufacturers, analysts say.

    Another category of drugs excluded from the price control regime by the DPCO 2019 is orphan drugs. This provision is likely to incentivize research into drugs that treat rare diseases where the R&D investments are comparatively less.

    Further, the new amendment brings in certain flexibility for fixation and revision of prices of drugs. The notification says “the source of market-based data shall be the data available with the pharmaceutical market data specializing company as decided by the government.” This means the NPPA can consider the data provided by any pharmaceutical market data specialized company. Also, it allows the said statistical data for any month and does not necessarily require such data to be of the preceding months. This is a step to get rid of the ongoing practice of relying upon a one-stop data source and analysis of the data from preceding months as they posed practical problems.

    According to the ministry, the DPCO 2019 would pave way for Indian patients getting access to drugs which are, otherwise, available only abroad. The move is meant to incentivize companies, to encourage them to manufacture drugs for rare diseases. And the most powerful incentive is to grant exclusive marketing rights to them.

    Meanwhile, healthcare NGOs and civil rights activists slammed the initiative as being “against the interest of the patients.”

    The policy change can only lead to monopolistic practices leaving the patients at the mercy of pharma giants who charge exorbitant prices. It also contravenes the agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), to which India is a signatory. India always stood for stronger implementation of TRIPS flexibilities.

    Freeing up orphan drugs from price control went against the National Policy for the Treatment of Rare Diseases. NPTRD itself was an outcome of orders passed by the judiciary in cases filed by patients struggling to access highly priced drugs. The policy was framed on the basis of recommendations of three expert committees, which noted the prohibitive costs of treatments. NPTRD 2017 India lists 450 such rare diseases, including hereditary cancers, congenital malformations and autoimmune disorders, they argue.


    S. Harachand
    Contributing Editor

    S. Harachand is a pharmaceutical journalist based in Mumbai. He can be reached at harachand@gmail.com.
    Related Searches
    • quality
    • patients
    • intellectual property
    • orphan
    Suggested For You
    Softweb Solutions Softweb Solutions
    A Different Kind of CRO A Different Kind of CRO
    ANI Pharmaceuticals ANI Pharmaceuticals
    Evotec AG, Immuneering in Discovery Alliance Evotec AG, Immuneering in Discovery Alliance
    Advanced Treatments in Rare Diseases Advanced Treatments in Rare Diseases
    Pharma Future: Trends to Watch Pharma Future: Trends to Watch
    Tedor Appoints Formulation Development Head Tedor Appoints Formulation Development Head
    PPD Adds New Therapeutic Area Professionals  PPD Adds New Therapeutic Area Professionals
    Idifarma, Palobiofarma Enter Partnership Idifarma, Palobiofarma Enter Partnership
    CANbridge, WuXi Biologics Enter Partnership CANbridge, WuXi Biologics Enter Partnership
    HPAPI Technology Trends HPAPI Technology Trends
    Clinical Trial Supplies Planning and Management Clinical Trial Supplies Planning and Management
    Finding the Right Partner Finding the Right Partner
    Olon Acquires Manufacturing Facility in India Olon Acquires Manufacturing Facility in India
    Achillion Pharmaceuticals Appoints EVP & COO Achillion Pharmaceuticals Appoints EVP & COO

    Related Back Page

    • Aseptic Processing | Facilities | Fill/Finish | Parenterals
      The Future of Pharmaceutical Manufacturing

      The Future of Pharmaceutical Manufacturing

      Innovative multi-product facility and equipment design.
      Steve Nole, VP of Operations, Grand River Aseptic Manufacturing 01.27.21

    • Cell & Gene Therapy Supply Chain: Early Preparation is Key

      Cell & Gene Therapy Supply Chain: Early Preparation is Key

      Supply chain management for cell and gene therapies requires precise demand planning and forecasting.
      Matthew Farabaugh, Chief Financial Officer, The Discovery Labs 11.17.20

    • Biologics, Proteins, Vaccines | Biosimilars | R&D
      The Global Biotech Boom

      The Global Biotech Boom

      How an industry grew to lead health care innovation and how CROs are adapting to meet their needs.
      Davide Garrisi, PPD Biotech 09.09.20


    • Speeding Vaccine Development with Advanced Analytics

      Speeding Vaccine Development with Advanced Analytics

      Having immediate access to wide ranging resources of data can help speed the COVID-19 vaccine development process
      Dr. Shlomi Madar, VP of Healthcare Solutions, Signals Analytics 05.05.20

    • APIs
      SOPs to Spur Growth in API Manufacturing

      SOPs to Spur Growth in API Manufacturing

      CMOs see outsourcing prospects improve
      S. Harachand, Contributing Editor 04.01.20

    • Trends Affecting the Generic Drugs Sector in 2020

      Trends Affecting the Generic Drugs Sector in 2020

      Supply chain issues, the need for additional talent chemists, lower drug prices, growth of development in the U.S. will be key factors.
      Ed Price, President, Seqens NA 03.04.20


    • QA/QC
      Quality Management: Preserving and Perpetuating Your Record

      Quality Management: Preserving and Perpetuating Your Record

      CDMOs must ensure that their top priority be delivering the highest quality products.
      Colleen Herczak, Vice President of Quality, Grand River Aseptic Manufacturing 01.28.20

    • Injectables
      Pitfalls to Avoid When Packaging Injectable Drug Products

      Pitfalls to Avoid When Packaging Injectable Drug Products

      Addressing legacy systems, lack of innovation adoption, and special challenges of New Molecular Entities.
      Fran DeGrazio, VP, Scientific Affairs and Technical Services, West Pharmaceutical Services 11.20.19

    • Information Technology
      Data Management in Life Sciences: Then and Now

      Data Management in Life Sciences: Then and Now

      A look at landmark changes in the management of data in the life sciences over the last 20 years and how the industry has addressed the challenges these develop
      Jason Lacombe, CEO, Veratrak 10.15.19


    • Clinical Trials | Information Technology
      Virtual Trials: Are they living up to their hype?

      Virtual Trials: Are they living up to their hype?

      This innovative approach is less costly, more patient-friendly, and delivers better quality data however, many stakeholders are still uncertain
      Josh Rose, VP R&D Global Strategy and Head of Virtual Trial Solutions, IQVIA 09.16.19

    • Avoiding Death by Spreadsheet

      Avoiding Death by Spreadsheet

      Cloud ERP systems are ushering in a new era of supply chain management
      Michael Kolias, QAD 06.13.19

    • Biologics, Proteins, Vaccines | Biosimilars
      Biotech Booms in the Yangtze River Valley

      Biotech Booms in the Yangtze River Valley

      A look at forces shaping the course of biotech growth in China
      Daniel Burch, M.D., Global Medical Officer, PPD Biotech 05.07.19


    • Logistics | Supply Chain
      Pharma Distribution: Powering the Supply Chain Today & Shaping What’s Next

      Pharma Distribution: Powering the Supply Chain Today & Shaping What’s Next

      The role of pharmaceutical distributors in the increasingly complex supply chain
      Akin Odutola, AmerisourceBergen 01.25.19

    • Injectables | Parenterals
      Injectables Go Deeper

      Injectables Go Deeper

      Generic majors set sights on complex sterile injectables
      S. Harachand, Contributing Editor 11.14.18

    • Biologics, Proteins, Vaccines | Clinical Trials
      Getting to First-in-Human Clinical Trials

      Getting to First-in-Human Clinical Trials

      A make-or-break milestone for small biopharmas
      David Kenyon, Patheon 10.10.18

    Trending
    • Catalent Acquires Delphi Genetics
    • BMS Expands Cell Therapy Manufacturing Capabilities
    • AbbVie Opts To Acquire Mitokinin
    • Four Female Leaders Appointed To Cell & Gene CDMO
    • WuXi AppTec Completes OXGENE Acquisition
    Breaking News
    • Amgen to Acquire Five Prime Therapeutics for $1.9B
    • Genesis Drug Discovery & Development Acquires Integrated Analytical Solutions
    • CureVac, Novartis Ink COVID Vax Mfg. Pact
    • Innoforce and dMed Enter Development Collaboration
    • Matica Biotechnology Breaks Ground on Cell and Gene Therapy Site
    View Breaking News >
    CURRENT ISSUE

    March 2021

    • Hygienic Packaging Technology
    • Trends in Solid Oral Dosage Delivery
    • 5 Reasons Paper Has No Place in Contract Manufacturing
    • Injectable Drug Delivery Trends
    • Pharmaceutical Manufacturing Equipment Trends
    • Oral Solids: Market & Technology Trends
    • Nutraceutical Manufacturing: Meeting the Challenges of Today, Planning for Tomorrow
    • 2021 Contract Manufacturing Survey
    • Small Molecule Development Trends
    • Challenges & Opportunities Facing Small & Emerging Biopharma Companies
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    IFT Transitions 2021 Annual Event to Digital Experience
    NY Federal Judge Enters Permanent Injunction Against Dietary Supplement Manufacturer
    Statins May Contribute to Vascular Calcification by Inhibiting Vitamin K-Dependent Proteins
    Coatings World

    Latest Breaking News From Coatings World

    Chromaflo Technologies Adds Benjamin Woeste as Territory Sales Manager
    Maroon Group Acquires Cary Company's Raw Materials, Specialty Chemicals Distribution Business
    Matt Fogel Named Mule-Hide's Territory Manager – Southern Virginia
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    EchoNous Expands Its Kosmos Hardware Platform
    Medtronic Begins Trial to Assess Novel Ablation Tech to Treat AFib
    Europe's Cross-Border Medtech Deal Activity Rises in Q4 2020
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Amgen to Acquire Five Prime Therapeutics for $1.9B
    Genesis Drug Discovery & Development Acquires Integrated Analytical Solutions
    CureVac, Novartis Ink COVID Vax Mfg. Pact
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Estée Lauder Establishes Equity and Engagement Center of Excellence
    L'Oreal On How It Will Shape Beauty's Future at Today's Transparency Summit
    C.O. Bigelow Earns Praise as NYC's Oldest Family-Run Apothecary
    Happi

    Latest Breaking News From Happi

    Avon Launches Vegan Skin Care Line
    Inolex Appoints VP Marketing
    Decorté Launches AI Diagnostics in US
    Ink World

    Latest Breaking News From Ink World

    Massilly North America Adds Koenig & Bauer MetalStar 3 Metal Decorating Press
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Access Direct Mail Doubles Revenue with SCREEN's Truepress Jet520HD
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Henkel publishes 30th Sustainability Report
    Avery Dennison Smartrac launches new Circus Pro inlays
    Springfield Solutions highlights digital label embellishments
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    FPInnovations Develops Biodegradable Mask
    Sani Professional Sanitizing and Disinfecting Products Approved by EPA
    Autefa Solutions Offers Fully Automated Line for Protective Mask Production
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Bioventus Appoints Managing Director, China and Asia Pacific
    Full-Year Sales Down 12 Percent at Zimmer Biomet
    Lincotek Medical Expands Coatings and Additive Capacity
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login